Skip to main content
SpringerLink
Log in

Onbrez Breezhaler reimbursed in Saskatchewan and British Columbia

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Novartis Pharmaceuticals Canada Inc. Now available as a drug plan benefit in Saskatchewan, (Pr)ONBREZ* BREEZHALER*, a once-daily bronchodilator for chronic obstructive pulmonary disease (COPD). Media Release : 10 Jul 2013. Available from: URL: http://www.novartis.ca.

  2. Novartis Pharmaceuticals Canada Inc. Now available as a British Columbia PharmaCare Benefit, (Pr)ONBREZ* BREEZHALER*, a once-daily bronchodilator for chronic obstructive pulmonary disease (COPD). Media Release : 10 Jul 2013. Available from: URL: http://www.novartis.ca.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Onbrez Breezhaler reimbursed in Saskatchewan and British Columbia. PharmacoEcon Outcomes News 683, 11 (2013). https://doi.org/10.1007/s40274-013-0586-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0586-0

Search

Navigation